6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
6m ago	Goodman Group Announces Results of Cash Tender Offer for its 3.700% Guaranteed Senior Notes due 2028
6m ago	FGR enters agreement to acquire advanced graphene coatings companies
6m ago	H2G Green Limited's GasHub Commissions Major LNG Facility for Renowned Large-Scale Laundry Provider
1h ago	Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
1h ago	Agibank Closes Second FIDC Structuring, Raises R$2.5 Billion

About

Haemonetics Corporation (NYSE:HAE) — investor relations, events, news, and company updates on 6ix.

Latest News

New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

Financials

Revenue

$1.32 B

Market Cap

$2.66 B

P/E Ratio

15.66

EPS

3.63

Community Chat

Ask AI